High-risk features and tumor differentiation in retinoblastoma: A retrospective histopathologic study

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 8, 2009, Pages 1203-1209

  Eagle Jr , Ralph C ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENUCLEATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GLAUCOMA; GROUPS BY AGE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; IRIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEOVASCULARIZATION (PATHOLOGY); OPTIC NERVE TUMOR; PHOTORECEPTOR CELL; RETINOBLASTOMA; ROSETTE FORMATION; TUMOR VASCULARIZATION; UVEA TUMOR; PATHOLOGY; PRESCHOOL CHILD; RETINA TUMOR; RETROSPECTIVE STUDY; RISK FACTOR;

CHILD, PRESCHOOL; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 69149106346     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12): 2276-2280. (Pubitemid 44838917)
2. Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001;119(1):41-48. (Pubitemid 32096384)
3. Biswas J, Das D, Krishnakumar S, et al. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40(5):265-267. (Pubitemid 37169693)
4. Chantada GL, Dunkel IJ, de Dávila MT, et al. Retinoblastoma patients with high-risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88(8):1069-1073.
5. Carbajal UM. Metastasis in retinoblastoma. Am J Ophthalmol. 1959;48(1): 47-49.
6. Redler LD, Ellsworth RM. Prognostic importance of choroidal invasion in retinoblastoma. Arch Ophthalmol. 1973;90(4):294-296.
7. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987; 94(4):371-377. (Pubitemid 17056025)
8. Messmer EP, Heinrich T, Hopping W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98(2):136-141.
9. Shields CL, Shields JA, Baez KA, et al. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548.
10. Khelfaoui F, Validire P, Auperin A, et. al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213. (Pubitemid 26080915)
11. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40(5):265-270. (Pubitemid 37169693)
12. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-222.
13. Shields CL, Shields JA, Baez KA, et al. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer. 1994;73(3):692-698.
14. Walton DS, Grant WM. Retinoblastoma and iris neovascularization. Am J Ophthalmol. 1968;65(4):598-599.
15. Yoshizumi MO, Thomas JV, Smith TR. Glaucoma-inducing mechanisms in eyes with retinoblastoma. Arch Ophthalmol. 1978;96(1):105-110.
16. Spaulding G. Rubeosis iridis and retinoblastoma and pseudoglioma. Trans Am Ophthalmol Soc. 1978;76:584-609.
17. Pe'er J, Neufeld M, Baras M, et. al. Rubeosis iridis in retinoblastoma: histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology. 1997;104(8):1251-1258.
18. Madhavan J, Ganesh A, Roy J, et. al. The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2008;45(1):22-25.
19. Ts'o MO, Zimmerman LE, Fine BS. The nature of retinoblastoma, I: photoreceptor differentiation - a clinical and histopathologic study. Am J Ophthalmol. 1970;69(3):339-349.
20. Ts'o MO, Fine BS, Zimmerman LE. The nature of retinoblastoma, II: photoreceptor differentiation - an electron microscopic study. Am J Ophthalmol. 1970;69(3):350-359.
21. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer. 1982;45(4):513-521.
22. Margo C, Hidayat A, Kopelman J, Zimmerman LE. Retinocytoma: a benign variant of retinoblastoma. Arch Ophthalmol. 1983;101(10):1519-1531.
23. Singh AD, Santos CM, Shields CL, et. al. Observations on 17 patients with retinocytoma. Arch Ophthalmol. 2000;118(2):199-205.
24. Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;17(10):1363-1372. (Pubitemid 351627333)
25. Gallie BL, Campbell C, Devlin H, et al. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 1999;59(suppl 7): 1731s-1735s. (Pubitemid 29165246)
26. Eagle RC Jr, Shields JA, Donoso L, et al. Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology. 1989;96(9):1389-1395. (Pubitemid 19231770)
27. Demirci H, Eagle RC Jr, Shields CL, et. al. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol. 2003; 121(8):1125-1131. (Pubitemid 36962166)
28. Ts'o MO, Zimmerman LE, Fine BS, et al. A cause of radioresistance in retinoblastoma: photoreceptor differentiation. Trans Am Acad Ophthalmol Otolaryngol. 1970;74(5):959-969.